Stock Events

Stock Events

Search...

Corvus Pharmaceuticals (CRVS) Q4 2023 Earnings

19MarConfirmed

Q1 2023

Q2 2023

Q3 2023

Q4 2023

-0.17

-0.15

-0.14

-0.12

Details

Expected EPS

-0.12

Actual EPS

-0.14

Surprise EPS

-0.02

Surprise Percent

+16.67%

Description

Corvus Pharmaceuticals (CRVS) has reported earnings of -0.14 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.